The U.S. Food and Drug Administration on Monday approved the first-ever GLP-1 pill for obesity from Wegovy maker Novo Nordisk, a landmark decision that health experts say could open up treatment acce… [+5222 chars]Read More
FDA approves first GLP1 pill for obesity from Wegovy maker Novo Nordisk CNBC
